Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response

Clin Cancer Res. 2024 Feb 1;30(3):639. doi: 10.1158/1078-0432.CCR-23-3603.

¹ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
³ Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
⁵ Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

No abstract available

Publication types